Stock listing
TSXV:ASG Aurora Spine Corp. Stock
Home listing (TSXV) of Aurora Spine Corp.
Follow Aurora Spine Corp. into a list and get an email when it puts out news.
Share price · TSXV:ASG
$0.08 CAD 0.00 (0.0%)
Close on Nov 19, 2026
- Day range
- $0.08 – $0.08 CADNov 19, 2026
- Market cap
- $6.25M CADAt the close on Nov 19, 2026 · price × 78.09M shares outstanding
- 52-week range
- $0.07 – $0.315 CADLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
- Traded on an average day
- $2,349 CADMedian day 2,111 shares · 23 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSXV:ASG · Home | $0.08 CAD | 0.00 (0.0%) | — | $0.08 | $0.08 | $0.08 | $0.08 | Close on Nov 19, 2026 |
| OTC:ASAPF | $0.052 USD | -0.008 (-13.8%) | 25,000 | $0.052 | $0.052 | $0.052 | $0.060 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 19, 2026 – Nov 19, 2026 · TSXV:ASG · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.08 | 0.00 | 0.0% | $0.08 | $0.08 | $0.08 | 0 | |
| $0.08 | -0.015 | -15.8% | $0.085 | $0.085 | $0.07 | 47,026 | |
| $0.095 | 0.00 | 0.0% | $0.095 | $0.095 | $0.095 | 0 | |
| $0.095 | 0.00 | 0.0% | $0.095 | $0.095 | $0.095 | 0 | |
| $0.095 | -0.005 | -5.0% | $0.095 | $0.095 | $0.095 | 1,000 | |
| $0.10 | 0.00 | 0.0% | $0.10 | $0.10 | $0.10 | 0 | |
| $0.10 | +0.01 | +11.1% | $0.10 | $0.10 | $0.10 | 1,504 | |
| $0.09 | -0.01 | -10.0% | $0.10 | $0.10 | $0.09 | 19,717 | |
| $0.10 | 0.00 | 0.0% | $0.105 | $0.105 | $0.10 | 1,000 | |
| $0.10 | 0.00 | 0.0% | $0.095 | $0.105 | $0.095 | 20,000 | |
| $0.10 | 0.00 | 0.0% | $0.10 | $0.10 | $0.10 | 0 | |
| $0.10 | -0.015 | -13.0% | $0.10 | $0.10 | $0.10 | 2,222 | |
| $0.115 | +0.015 | +15.0% | $0.115 | $0.115 | $0.115 | 21,000 | |
| $0.10 | -0.015 | -13.0% | $0.115 | $0.115 | $0.10 | 164,021 | |
| $0.115 | -0.005 | -4.2% | $0.125 | $0.125 | $0.115 | 12,000 | |
| $0.12 | 0.00 | 0.0% | $0.12 | $0.12 | $0.12 | 0 | |
| $0.12 | 0.00 | 0.0% | $0.12 | $0.12 | $0.12 | 0 | |
| $0.12 | -0.01 | -7.7% | $0.12 | $0.12 | $0.12 | 131,515 | |
| $0.13 | +0.005 | +4.0% | $0.13 | $0.13 | $0.13 | 500 | |
| $0.125 | -0.005 | -3.8% | $0.125 | $0.125 | $0.125 | 40,000 | |
| $0.13 | +0.01 | +8.3% | $0.125 | $0.13 | $0.125 | 1,000 | |
| $0.12 | 0.00 | 0.0% | $0.12 | $0.12 | $0.12 | 0 | |
| $0.12 | 0.00 | 0.0% | $0.12 | $0.12 | $0.12 | 0 | |
| $0.12 | 0.00 | 0.0% | $0.12 | $0.12 | $0.12 | 6,500 | |
| $0.12 | 0.00 | 0.0% | $0.12 | $0.12 | $0.12 | 0 | |
| $0.12 | -0.02 | -14.3% | $0.13 | $0.13 | $0.12 | 53,000 | |
| $0.14 | 0.00 | 0.0% | $0.14 | $0.14 | $0.14 | 500 | |
| $0.14 | 0.00 | 0.0% | $0.14 | $0.14 | $0.14 | 7,800 | |
| $0.14 | +0.01 | +7.7% | $0.13 | $0.14 | $0.13 | 72,000 | |
| $0.13 | 0.00 | 0.0% | $0.13 | $0.13 | $0.13 | 0 | |
| $0.13 | -0.005 | -3.7% | $0.13 | $0.13 | $0.13 | 13,000 | |
| $0.135 | -0.005 | -3.6% | $0.135 | $0.135 | $0.135 | 2,000 | |
| $0.14 | 0.00 | 0.0% | $0.14 | $0.14 | $0.14 | 0 | |
| $0.14 | 0.00 | 0.0% | $0.14 | $0.14 | $0.14 | 0 | |
| $0.14 | +0.01 | +7.7% | $0.15 | $0.15 | $0.14 | 5,000 | |
| $0.13 | -0.02 | -13.3% | $0.135 | $0.135 | $0.13 | 3,000 | |
| $0.15 | +0.015 | +11.1% | $0.15 | $0.15 | $0.15 | 1,500 | |
| $0.135 | 0.00 | 0.0% | $0.135 | $0.135 | $0.135 | 0 | |
| $0.135 | 0.00 | 0.0% | $0.135 | $0.135 | $0.135 | 0 | |
| $0.135 | +0.005 | +3.8% | $0.135 | $0.135 | $0.135 | 51,000 | |
| $0.13 | -0.02 | -13.3% | $0.13 | $0.13 | $0.13 | 3,000 | |
| $0.15 | 0.00 | 0.0% | $0.15 | $0.15 | $0.15 | 0 | |
| $0.15 | 0.00 | 0.0% | $0.15 | $0.15 | $0.15 | 0 | |
| $0.15 | 0.00 | 0.0% | $0.15 | $0.15 | $0.15 | 0 | |
| $0.15 | +0.005 | +3.4% | $0.15 | $0.15 | $0.15 | 1,000 | |
| $0.145 | 0.00 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | -0.005 | -3.3% | $0.125 | $0.145 | $0.125 | 2,500 | |
| $0.15 | 0.00 | 0.0% | $0.15 | $0.15 | $0.15 | 21,000 | |
| $0.15 | -0.005 | -3.2% | $0.155 | $0.155 | $0.15 | 29,600 | |
| $0.155 | -0.005 | -3.1% | $0.165 | $0.165 | $0.155 | 6,500 | |
| $0.16 | 0.00 | 0.0% | $0.18 | $0.18 | $0.16 | 18,500 | |
| $0.16 | -0.02 | -11.1% | $0.19 | $0.20 | $0.16 | 81,500 | |
| $0.18 | 0.00 | 0.0% | $0.18 | $0.18 | $0.18 | 15,500 | |
| $0.18 | 0.00 | 0.0% | $0.18 | $0.18 | $0.18 | 0 | |
| $0.18 | -0.02 | -10.0% | $0.195 | $0.20 | $0.18 | 30,000 | |
| $0.20 | +0.01 | +5.3% | $0.19 | $0.20 | $0.19 | 27,000 | |
| $0.19 | +0.005 | +2.7% | $0.18 | $0.19 | $0.18 | 33,000 | |
| $0.185 | -0.02 | -9.8% | $0.19 | $0.19 | $0.155 | 81,000 | |
| $0.205 | +0.015 | +7.9% | $0.205 | $0.205 | $0.205 | 5,100 | |
| $0.19 | 0.00 | 0.0% | $0.19 | $0.19 | $0.19 | 0 | |
| $0.19 | -0.025 | -11.6% | $0.215 | $0.215 | $0.19 | 47,700 | |
| $0.215 | -0.005 | -2.3% | $0.215 | $0.215 | $0.215 | 9,500 | |
| $0.22 | 0.00 | 0.0% | $0.22 | $0.22 | $0.22 | 0 | |
| $0.22 | 0.00 | 0.0% | $0.22 | $0.22 | $0.22 | 0 |
- Ticker
- TSXV:ASG
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- TSXV
- Currency
- CAD
What changed lately
Latest news release · Oct 22, 2026
Aurora Spine Announces Publication of REFINE Study's 12-Month Results in the International Journal of Spine Surgery
Latest earnings call · May 28, 2026
Aurora Spine (TSXV:ASG) Q1 2026 Earnings Call
Replay and transcript
Latest deck · May 2026
Lytham Partners Spring 2026 Investor Conference
Conference · 17 slides
Latest news
Aurora Spine Announces Publication of REFINE Study's 12-Month Results in the International Journal of Spine Surgery
Oct 22, 2026
Closed $0.125 (-3.8%) on Oct 23, 2026
Aurora Spine Corporation Announces Amendment to Loan from Insider
Sep 29, 2026
Closed $0.14 (+7.7%) on Sep 30, 2026
Aurora Spine Corporation Announces Second Quarter FY26 Financial Results
Aug 27, 2026
Closed $0.185 (-9.8%) on Aug 27, 2026
Aurora Spine Announces Settlement of Arbitration, New Patent License Agreement for SI Joint Product and Increase in Funding from Insider
Aug 14, 2026
Closed $0.215 (+2.4%) on Aug 17, 2026
Aurora Spine and CornerLoc Announce Strategic Commercial Alliance to Expand Minimally Invasive Spine and SI Joint Solutions Nationwide
Jul 16, 2026
Closed $0.235 (-6.0%) on Jul 16, 2026
Aurora Spine Grants Stock Options
Jun 9, 2026
Closed $0.23 (0.0%) on Jun 10, 2026
Aurora Spine Corporation Announces First Quarter FY26 Financial Results
May 28, 2026
Closed $0.245 (0.0%) on May 28, 2026
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2026 Financial Results
May 26, 2026
Closed $0.245 (+4.3%) on May 27, 2026
Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants
May 7, 2026
Closed $0.245 (+4.3%) on May 7, 2026
Aurora Spine Corporation Announces Record Fourth Quarter and FY25 Financial Results
Apr 30, 2026
Closed $0.275 (-1.8%) on Apr 30, 2026
Aurora Spine Corp. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 14 in the last 12 months · 44 in all · newest Oct 22, 2026 · oldest 2013
- Calls
- 18 calls with a replay · 18 with a transcript · latest May 28, 2026
- Decks
- 4 decks · latest May 2026
Where Aurora Spine Corp. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSXV:ASG · Home listing · This page | TSXV | Canada | CAD |
| OTC:ASAPF | OTC | United States | USD |
| Cboe Canada:ASG | Cboe Canada | Canada | CAD |
Cash and shares
May 2026 deck · Aurora Spine — Lytham Partners Spring 2026 Investor Conference
- Shares outstanding
- 78.1 million
Valuation
EV/sales 0.4× against a median of 0.2×: 5th lowest of 8 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 19, 2026
- Enterprise value
- $9.91M CAD
- P/E
- Loss
- EV/sales
- 0.4×
- EV/EBITDA
- 45.6×
- Price/book
- 1.5×
- Gross margin
- 61.6%
- Operating margin
- −5.1%
- Net margin
- −7.0%
- Debt to equity
- 1.0×
- Beta vs S&P/TSX Composite
- -0.13
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Aurora Spine Corp. · TSXV:ASG | US$4.36M | US$6.91M | n/a | 0.4× | 45.6× | 1.5× | −7.0% | 1.0× | -0.13 |
| MEKICS Co., Ltd. · KRX:058110 | US$5.23M | US$2.04M | 6.6× | 0.2× | 1.3× | 0.2× | 7.7% | 0.1× | n/a |
| PT Hetzer Medical Indonesia Tbk · IDX:MEDS | US$5.16M | US$5.45M | n/a | n/a | n/a | 1.8× | n/a | 0.1× | n/a |
| Regentis Biomaterials Ltd. · AMEX:RGNT | US$5.05M | −US$3.90M | n/a | n/a | n/a | 0.7× | n/a | 0.0× | 2.00 |
| SeaStar Medical Holding Corporation · NASDAQ:ICU | US$4.97M | US$981,429 | n/a | 0.5× | n/a | 10.6× | −678.2% | 0.0× | 1.44 |
| WORK Medical Technology Group LTD · NASDAQ:WOK | US$4.84M | US$8.21M | n/a | 0.8× | n/a | 0.2× | −10.9% | 0.2× | 2.76 |
| Kelyniam Global, Inc. · OTC:KLYG | US$4.56M | US$4.84M | n/a | 1.4× | 31.9× | 6.6× | −6.0% | 0.6× | 1.15 |
| Meihua International Medical Technologies Co., Ltd. · OTC:MHUAF | US$4.53M | −US$1.63M | 0.7× | −0.0× | −0.2× | 0.0× | 11.0% | 0.1× | 0.62 |
| IceCure Medical Ltd. · NASDAQ:ICCM | US$3.71M | −US$3.80M | n/a | −1.0× | n/a | 0.4× | −439.7% | 0.1× | 1.98 |
| enVVeno Medical Corporation · NASDAQ:NVNO | US$3.65M | −US$14.82M | n/a | n/a | n/a | 0.2× | n/a | 0.0× | 1.12 |
| Spineway SA · EURONEXT:ALSPW | US$3.63M | US$1.46M | n/a | 0.1× | n/a | 0.1× | −18.0% | 0.1× | n/a |
| Median of the others | US$4.70M | US$1.22M | 3.7× | 0.2× | 1.3× | 0.3× | −10.9% | 0.1× | 1.44 |
Team and board
| Officer | Role |
|---|---|
| Trent Northcutt | CEO |
| Chad Clouse | Chief Financial Officer |
| David Meyer | CLO / Vice President |
| Katelyn Sims | Vice President of Commercialization & Key Accounts |
| Kenneth Scott Carnahan | Vice President of Education |
| Matt Paxton | Executive Vice President of Sales |
| Ron Eckels | Global Vice President of Spine |
| Laszlo Garamszegi | CTO / Co-Founder |
| Matthew Goldstone | Chief Commercial Officer |
Events
Calls
| Call | When | Status |
|---|---|---|
| Aurora Spine (TSXV:ASG) Q1 2026 Earnings Call | Thu, May 28, 2026 · 10:00 AM ET | Replay |
| Aurora Spine (TSXV:ASG) Q4 2025 Earnings Call | Thu, Apr 30, 2026 · 11:00 AM ET | Replay |
| Aurora Spine (TSXV:ASG) Q3 2025 Earnings Call | Tue, Nov 18, 2025 · 11:00 AM ET | Replay |
| Aurora Spine (TSXV:ASG) Q2 2025 Earnings Call | Tue, Sep 02, 2025 · 11:00 AM ET | Replay |
| Aurora Spine (TSXV:ASG) Q1 2025 Earnings Call | Thu, May 22, 2025 · 11:00 AM ET | Replay |
| Aurora Spine (TSXV:ASG) Q4 2024 Earnings Call | Tue, Apr 29, 2025 · 11:00 AM ET | Replay |
| Aurora Spine (TSXV:ASG) Q3 2024 Earnings Call | Mon, Oct 28, 2024 · 11:00 AM ET | Replay |
| Aurora Spine (TSXV:ASG) Q2 2024 Earnings Call | Fri, Aug 23, 2024 · 11:00 AM ET | Replay |
| Aurora Spine (TSXV:ASG) Q1 2024 Earnings Call | Tue, May 14, 2024 · 11:00 AM ET | Replay |
| Aurora Spine (TSXV:ASG) Q3 2023 Earnings Call | Wed, Nov 15, 2023 · 11:00 AM ET | Replay |
All 18 calls
| Call | When | Status |
|---|---|---|
| Aurora Spine (TSXV:ASG) Q2 2023 Earnings Call | Tue, Aug 29, 2023 · 12:00 PM ET | Replay |
| Aurora Spine (TSXV:ASG) Q1 2023 Earnings Call | Wed, May 24, 2023 · 12:00 PM ET | Replay |
| Aurora Spine (TSXV:ASG) Q4 2022 Earnings Call | Mon, May 01, 2023 · 12:00 PM ET | Replay |
| Aurora Spine (TSXV:ASG) Q3 2022 Earnings Call | Mon, Nov 21, 2022 · 11:00 AM ET | Replay |
| Aurora Spine (TSXV:ASG) Q2 2022 Earnings Call | Mon, Aug 29, 2022 · 11:00 AM ET | Replay |
| Aurora Spine (TSXV:ASG) Q1 2022 Earnings Call | Tue, May 24, 2022 · 11:00 AM ET | Replay |
| Aurora Spine (TSXV:ASG) Q4 2021 Earnings Call | Mon, May 02, 2022 · 1:10 PM ET | Replay |
| Aurora Spine (TSXV:ASG) Q3 2021 Earnings Call | Tue, Nov 16, 2021 · 4:30 PM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 19, 2026 · After close | |
| Q1 2023 | May 24, 2023 · Before open | −15.2% |
| Q3 2022 | Nov 21, 2022 · Before open | 0.0% |
| Q2 2022 | Aug 29, 2022 · Before open | 0.0% |
| Q1 2022 | May 23, 2022 · Before open | −6.3% |
| Q3 2021 | Nov 16, 2021 | +1.4% |
| Quarter to Jun 30, 2021 | Aug 26, 2021 | +3.0% |
| Quarter to Mar 31, 2021 | May 27, 2021 | +7.5% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Lytham Partners Spring 2026 Investor Conference | Conference | 17 slides | May 2026 |
| Investor Presentation (February 2026) | Investor deck | 30 slides | February 2026 |
| Investor Presentation (2025) | Investor deck | 29 slides | 2025 |
| Investor Presentation (2025) | Investor deck | 28 slides | 2025 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18.4M | 17.6M | 14.5M | 14.9M | 10.5M | 8.65M | 11.2M | 8.68M | 5.99M | 6.76M |
| Cost of revenue | 7.17M | 6.93M | 6.31M | 7.07M | 5.71M | 5.18M | 7.61M | 4.09M | 3.43M | 3.37M |
| Gross profit | 11.2M | 10.6M | 8.21M | 7.81M | 4.83M | 3.47M | 3.55M | 4.59M | 2.56M | 3.38M |
| Research and development | 624.3K | 731.3K | 1.11M | 1.16M | 941.3K | 286.2K | 207.5K | 36.3K | 21.1K | 40.4K |
| Selling, general and administrative | 9.64M | 9.34M | 6.82M | 6.08M | 4.99M | 3.65M | 3.89M | 3.64M | 3.70M | 4.11M |
| Operating income | -330.0K | -484.5K | -1.50M | -1.57M | -2.71M | -1.25M | -1.25M | -56.1K | -2.33M | -1.68M |
| Depreciation and amortization | 1.07M | 1.01M | 1.05M | 868.6K | 648.7K | 589.5K | 386.6K | 780.6K | 826.2K | 762.0K |
| EBITDA | 740.8K | 522.9K | -446.2K | -700.7K | -2.06M | -661.6K | -866.8K | 724.4K | -1.50M | -917.2K |
| Interest expense | 168.3K | 175.1K | 185.2K | 163.6K | 159.1K | 90.8K | 174.0K | 147.6K | 144.7K | 60.9K |
| Income before tax | -731.1K | -1.00M | -1.68M | -1.50M | -2.36M | -232.1K | -1.25M | -68.2K | -2.24M | -1.68M |
| Income tax | 881.3K | 231.4K | 159.1K | 87.7K | 174.0K | 147.6K | 144.7K | 60.9K | ||
| Net income | -731.1K | -1.00M | -1.68M | -1.50M | -2.36M | -232.1K | -1.25M | -68.2K | -2.24M | -1.68M |
| Earnings per share, basic | -0.01 | -0.01 | -0.02 | -0.02 | -0.04 | -0.00 | -0.03 | -0.00 | -0.06 | -0.05 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 896.7K | 825.6K | 766.8K | 423.4K | 3.17M | 1.71M | 444.7K | 856.5K | 12.7K | 192.8K |
| Receivables | 3.31M | 3.14M | 3.97M | 3.67M | 2.67M | 1.66M | 2.44M | 1.58M | 811.5K | 1.23M |
| Inventory | 3.24M | 3.61M | 3.56M | 3.05M | 1.89M | 1.60M | 1.53M | 2.56M | 2.46M | 3.00M |
| Current assets | 7.80M | 7.88M | 8.50M | 7.33M | 8.41M | 5.20M | 4.68M | 5.22M | 3.76M | 4.74M |
| Property, plant and equipment | 1.30M | 1.09M | 1.16M | 766.6K | 1.27M | 2.10M | ||||
| Total assets | 10.4M | 11.1M | 12.0M | 10.1M | 10.6M | 7.16M | 6.67M | 6.84M | 5.29M | 7.04M |
| Accounts payable | 1.72M | 2.99M | 3.04M | 2.83M | 2.61M | 1.53M | 2.49M | 1.87M | 1.74M | 2.40M |
| Current liabilities | 3.35M | 3.27M | 3.27M | 3.03M | 2.63M | 1.56M | 2.52M | 1.87M | 1.74M | 2.40M |
| Long-term debt | 2.85M | 2.71M | 2.56M | 2.42M | 2.27M | 2.14M | 2.10M | 2.02M | 1.90M | 1.17M |
| Total debt | 3.65M | 2.97M | 2.38M | 2.34M | 2.41M | 2.02M | ||||
| Total liabilities | 6.59M | 6.66M | 6.69M | 5.81M | 4.99M | 3.87M | 4.91M | 3.88M | 3.64M | 3.57M |
| Shareholders' equity | 3.81M | 4.40M | 5.30M | 4.32M | 5.57M | 3.28M | 1.77M | 2.96M | 1.65M | 3.47M |
| Shares outstanding | 78.1M | 77.6M | 70.7M | 66.8M | 58.7M | 54.6M | 46.5M | 42.2M | 35.2M | 32.2M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 917.4K | 1.06M | -935.1K | -1.56M | -2.13M | 309.6K | 729 | 435.8K | -1.15M | -1.70M |
| Capital spending | -543.6K | -637.9K | -479.1K | -873.2K | -720.6K | -554.6K | -286.7K | -292.7K | -137.4K | -91.4K |
| Free cash flow | 373.8K | 420.0K | -1.41M | -2.43M | -2.85M | -245.1K | -286.0K | 143.1K | -1.28M | -1.79M |
| Cash from investing | -720.6K | -554.6K | -283.9K | -278.9K | 35.7K | -91.4K | ||||
| Cash from financing | -302.7K | -361.2K | 1.76M | -318.2K | 4.31M | 1.51M | -128.6K | 686.9K | 929.6K | 1.40M |
| Share buybacks | 350.2K | 394.2K | ||||||||
| Change in cash | 71.1K | 58.8K | 343.4K | -2.75M | 1.46M | 1.27M | -411.8K | 843.8K | -180.2K | -386.8K |
Cap table
Built by 6ix from Aurora Spine Corp.’s releases · as of Jun 30, 2026
- Common shares
- 78,092,199
- Fully diluted
- 80,112,199
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 78,092,199 | Jun 30, 2026 |
| Options and RSUs | 2,020,000 | Jun 8, 2026 |
Warrants and options
| Lot |
|---|
| Stock options · C$0.23 · expire about Jun 2031 |
Share count over time
| Count | Shares |
|---|---|
| Jun 30, 2026 | 78,092,199 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Chad Clouse | Chief Financial Officer · Since at least Oct 22, 2026 |
| David Meyer | CLO / Vice President · Since at least Nov 4, 2026 |
| Katelyn Sims | Vice President of Commercialization & Key Accounts · Since at least Nov 4, 2026 |
| Kenneth Scott Carnahan | Vice President of Education · Since at least Nov 4, 2026 |
| Laszlo Garamszegi | CTO / Co-Founder · Since at least Oct 22, 2026 |
| Matthew Goldstone | Chief Commercial Officer · Since at least Jun 10, 2025 |
| Matt Paxton | Executive Vice President of Sales · Since at least Nov 4, 2026 |
| Ron Eckels | Global Vice President of Spine · Since at least Sep 18, 2025 |
| Trent J. Northcutt | CEO · Since at least Oct 22, 2026 |
Log in to ask 6ix AI your own questions about Aurora Spine Corp.